ArticleJournal of hepatocellular carcinoma2023

Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Benjian Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.